2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
AFL atrial flutter AH arterial hypertension ANS autonomic nervous system APD action
potential duration ARREST-AF Aggressive Risk Factor Reduction Study for Atrial Fibrillation …
potential duration ARREST-AF Aggressive Risk Factor Reduction Study for Atrial Fibrillation …
[PDF][PDF] 2018 Korean guideline of atrial fibrillation management
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the general
population. The Korean Heart Rhythm Society organized a Korean AF Management …
population. The Korean Heart Rhythm Society organized a Korean AF Management …
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
The current manuscript is an update of the original Practical Guide, published in June 2013
[Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart …
[Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart …
[HTML][HTML] Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation
Background Catheter ablation of atrial fibrillation is typically performed with uninterrupted
anticoagulation with warfarin or interrupted non–vitamin K antagonist oral anticoagulant …
anticoagulation with warfarin or interrupted non–vitamin K antagonist oral anticoagulant …
Left atrial appendage isolation in patients with longstanding persistent AF undergoing catheter ablation: BELIEF trial
L Di Biase, JD Burkhardt, P Mohanty, S Mohanty… - Journal of the American …, 2016 - jacc.org
Background: Longstanding persistent (LSP) atrial fibrillation (AF) is the most challenging
type of AF. In addition to pulmonary vein isolation, substrate modification and triggers …
type of AF. In addition to pulmonary vein isolation, substrate modification and triggers …
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve …
Task Force Members, GYH Lip… - European heart …, 2014 - academic.oup.com
Atrial fibrillation (AF) confers a substantial risk of mortality and morbidity from stroke and
thrombo-embolism, and this common cardiac arrhythmia represents a major healthcare …
thrombo-embolism, and this common cardiac arrhythmia represents a major healthcare …
[PDF][PDF] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
F Casselman, A Coca, R De Caterina… - European heart …, 2016 - academia.edu
Surveys and registries are needed to verify that real-life daily practice is in kee** with what
is recommended in the guidelines, thus completing the loop between clinical research …
is recommended in the guidelines, thus completing the loop between clinical research …
Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
Aims VENTURE-AF is the first prospective randomized trial of uninterrupted rivaroxaban and
vitamin K antagonists (VKAs) in patients with non-valvular atrial fibrillation (NVAF) …
vitamin K antagonists (VKAs) in patients with non-valvular atrial fibrillation (NVAF) …
Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from …
L Di Biase, JD Burkhardt, P Santangeli, P Mohanty… - Circulation, 2014 - Am Heart Assoc
Background—Periprocedural thromboembolic and hemorrhagic events are worrisome
complications of catheter ablation for atrial fibrillation (AF). The periprocedural …
complications of catheter ablation for atrial fibrillation (AF). The periprocedural …
2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation
Atrial fibrillation (AF) is an extremely common clinical problem with an important population
morbidity and mortality burden. The management of AF is complex and fraught with many …
morbidity and mortality burden. The management of AF is complex and fraught with many …